Strategies emerge for chemotherapy de-escalation in HER2-positive breast cancer Presented ByDr Javier Cortés, Vall d’Hebron Institute of Oncology, Spain TrialPhase 2, PHERGAIN ConferenceASCO 2020 TypePeer-reviewed article 8 September 2020 08:50